🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Effectiveness of the "Aidant TLC" Program, Delivered in Person and Remotely, on the Well-being of Informal Caregivers

RecruitingNAAges 18 Years - anyAllInnovation Alzheimer
NCT07558356 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

As the population ages in France, more people need help with daily activities. Family members and other informal caregivers often provide this support, which can be physically and emotionally demanding and may affect their well-being. This study evaluates the "Aidant TLC (Thrive, Learn, Connect)" program, a support program designed to help caregivers better manage stress, emotions, and relationships. The program has been developed in the United States but has not yet been tested in France. The goal of this study is to compare the effects of the program when delivered in two formats: online (remote) and in person. A third group of participants will not receive the program during the study period but will be offered it afterward. A total of 75 caregivers will take part in the study. Participants will be randomly assigned to one of the three groups. The program consists of weekly group s

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Being an informal caregiver of an adult requiring assistance with activities of daily living * Providing at least 4 hours of care per week (broadly defined, including direct care as well as help with tasks such as medication management and bill payment) * French-speaking * Ability to travel (for the in-person intervention) to Nice or Biot (France) * Access to the internet at home or in an easily accessible location (for the remote intervention). Exclusion Criteria: * Inability to provide informed consent.
💊

What it tests

  • Psychoeducation
📍

Where

2 sites
Créapolis
Biot, France
Institut Claude Pompidou
Nice, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy